×
About 88 results
PRADAXA® (dabigatran etexilate mesylate) capsules
https://www.pradaxapro.com/

PRADAXA is the only NOAC with a specific reversal, available in all 50 states. See how PRADAXA compares to warfarin, and find dosing and coverage information. Please see Important Safety Information and full Prescribing Information, including boxed warning.

Lovenox® (enoxaparin sodium injection)
https://www.lovenox.com/

Find out more information about LOVENOX and how it may help your patients.

XARELTO (rivaroxaban) TABLETS
https://www.xareltohcp.com

XARELTO® is a prescription anticoagulant indicated to treat deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduce the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF). See Important Safety Info & full Prescribing Info, including Boxed WARNINGS.

SAVAYSA® (edoxaban) tablets
https://savaysahcp.com/

Learn about SAVAYSA® (edoxaban) a novel oral anticoagulant (NOAC). See Full Prescribing Information & Boxed Warnings.

Enoxaparin sodium - enoxaparin sodium injection-Amphastar Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e6bf2b3-9339-4104-bda3-ad86a1949703

Jan 12th, 2020 - Enoxaparin Sodium Injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness (1.1) Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) Outpatient treatment of acute DVT without p...

Fondaparinux sodium - fondaparinux sodium injection, solution-Zydus Pharmaceuticals (USA) Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dffbf7c9-495e-4a33-ac76-57b52f014fc2

Jan 9th, 2020 - Fondaparinux sodium injection is a Factor Xa inhibitor (anticoagulant) indicated for: Prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery. (1.1) Treatment of DVT or acute pulmonary embolism (PE) when administered in conjunction with warfarin. (1.2, 1.3) Fon...

Enoxaparin sodium - enoxaparin sodium injection-Fresenius Kabi USA, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a694bbc3-4eb0-4c1e-b4ff-b8abc3e5148e

Dec 18th, 2019 - Enoxaparin Sodium Injection is a low molecular weight heparin [LMWH] indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1) Inpatient treatment of acute DVT with or without pulmonary embolism ( 1.2) Outpatient treatment of acute DVT without...

Arixtra - fondaparinux sodium injection, solution-Mylan Institutional LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3b30c68-cf45-4b46-8ba6-72090f7ba01a

Dec 17th, 2019 - ARIXTRA is a Factor Xa inhibitor (anticoagulant) indicated for: •Prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery. (1.1) •Treatment of DVT or acute pulmonary embolism (PE) when administered in conjunction with warfarin. (1.2, 1.3) ARIXTRA® is indicated f...

Eliquis - apixaban tablet, film coated-Cardinal Health
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a454cd24-0c6d-46e8-b1e4-197388606175

Dec 15th, 2019 - ELIQUIS is a factor Xa inhibitor indicated: •to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. (1.1) •for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (1.2) •for the treatment of DVT and PE, and for the reduction in the risk of recurrent...

Enoxaparin sodium - enoxaparin sodium injection-NorthStar Rx LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32f8d292-0dda-4931-81ea-ba47e23edf61

Nov 30th, 2019 - Enoxaparin Sodium Injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness (1.1) Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) Outpatient treatment of acute DVT without p...

Enoxaparin sodium - enoxaparin sodium injection-Meitheal Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d42b7d26-6e72-4609-b95d-5b1bf280b9ed

Nov 30th, 2019 - Enoxaparin Sodium Injection is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness (1.1) Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) Outpatient treatment of acute DVT without p...

Eliquis 30-day starter pack - apixaban tablet, film coated-E.R. Squibb & Sons, L.L.C.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9481622-7cc6-418a-acb6-c5450daae9b0

Nov 25th, 2019 - ELIQUIS is a factor Xa inhibitor indicated: •to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. (1.1) •for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (1.2) •for the treatment of DVT and PE, and for the reduction in the risk of recurrent...

Enoxaparin sodium - enoxaparin sodium injection-Cardinal Health
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d38f7edd-fe2d-4ecc-baf7-86673279881d

Nov 8th, 2019 - Enoxaparin sodium is a low molecular weight heparin (LMWH) indicated for: •Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness (1.1) •Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) •Outpatient treatment of acute DVT without pulmonar...

Fragmin - dalteparin sodium injection-Pfizer Laboratories Div Pfizer Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23527b8b-9b28-4e6d-9751-33b143975ac7

Oct 15th, 2019 - FRAGMIN is a low molecular weight heparin (LMWH) indicated for Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction (1.1) Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery or medical patients with severely restricted mobility during acute illness (1.2) Extended treatment of symptomatic venous thromboembolism (VTE) to...

Raloxifene hydrochloride - raloxifene hydrochloride tablet, film coated-Prasco Laboratories
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44c89f9c-2194-4d33-9bde-f8f309d33ef2

Sep 23rd, 2019 - Recent Major Changes Section Contraindications, Pregnancy (4.2) 06/2018 Warnings and Precautions, Premenopausal Use (5.4)            06/2018 Boxed Warning Section Increased risk of deep vein thrombosis and pulmonary embolism have been reported with raloxifene hydrochloride [see Warnings and Precautions (5.1)]. Women with active or past history of venous thromboembolism should not take raloxif...

Raloxifene hydrochloride - raloxifene hydrochloride tablet, film coated-Aurobindo Pharma Limited
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8b6cbe0-c1f4-4678-b852-f629a7f6a1b5

Sep 15th, 2019 - Recent Major Changes Section Contraindications, Pregnancy (4.2) 06/2018 Warnings and Precautions, Premenopausal Use (5.4)            06/2018 Boxed Warning Section Increased risk of deep vein thrombosis and pulmonary embolism have been reported with raloxifene hydrochloride [see Warnings and Precautions (5.1)]. Women with active or past history of venous thromboembolism should not take raloxif...

Savaysa - edoxaban tosylate tablet, film coated-Daiichi Sankyo Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d3400-56ad-11e3-949a-0800200c9a66

Aug 25th, 2019 - SAVAYSA is a factor Xa inhibitor indicated: To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) (1.1) Limitation of Use for NVAF SAVAYSA should not be used in patients with creatinine clearance (CrCL) > 95 mL/min because of increased risk of ischemic stroke compared to warfarin at the highest dose studied (60 mg) (1.1) SAVAYSA is indic...

Xarelto - rivaroxaban tablet, film coated-Janssen Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610

Jul 16th, 2019 - XARELTO is a factor Xa inhibitor indicated: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (1.1) for the treatment of deep vein thrombosis (DVT) (1.2) for the treatment of pulmonary embolism (PE) (1.3) for the reduction in the risk of recurrence of DVT and/or PE in patients at continued risk for recurrent DVT and/or PE after completion of ini...

Enoxaparin sodium - enoxaparin sodium injection-Fresenius Kabi USA, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=066f27ec-352c-4051-ba29-248e292690db

Jul 10th, 2019 - Enoxaparin sodium is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness (1.1) Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) Outpatient treatment of acute DVT without pulmonary e...

Eliquis - apixaban tablet, film coated-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1be363d-6fc5-4b08-9b96-976933db19e1

Jul 6th, 2019 - ELIQUIS is a factor Xa inhibitor indicated: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. (1.1) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (1.2) for the treatment of DVT and PE, and for the reduction in the risk of recurrent DV...